Diabetes Victoria CEO Craig Bennett retires 25 March 2022 A special message from ºÚÁÏÍø Group CEO Justine Cain: “Today marks the end of an era, as Diabetes Victoria CEO Craig Bennett retires from the organisation he has lead tirelessly for the past nine years. He has led Diabetes Victoria as a modern, inclusive organisation committed to supporting people with diabetes. One of his most important achievements has been ensuring that the lived experience of people with diabetes is central to all aspects of the organisation. This includes establishing a vibrant Consumer Advisory Committee to tap into the rich knowledge and experience of the diabetes community. Craig has also been a major supporter of diabetes research including helping to secure more ºÚÁÏÍø Research Program funding for Victoria and attracting more support for the Australian Centre for Behavioural Research in Diabetes. Finally, he has established a strong evaluation capability within Diabetes Victoria to ensure the organisation’s programs and services are effective and evidence-based. On behalf of Australia’s diabetes community, I’d like to thank Craig for all his hard work. Your contribution will not be forgotten.”
Blog 1 June 2026 Rebuilding after the fall: Brett Findlay’s story of recovery and resilience Brett Findlay had just started a new job when he learnt he had type 1 diabetes. He figured he could manage diabetes by keeping his blood glucose levels consistently low. Then, one fateful day, he had a severe hypo. In this raw episode of Life on the Level, Brett talks about hypo unawareness, rebuilding after trauma, and the enduring strength of family. Continue Reading
Blog 1 June 2026 Life on the level podcast: returning for season 2Â Life on the Level podcast is back with season 2. Hosted by young Aussies Isabella Magee and Sebastian Harris, this season explores what it's really like to live with type 1 diabetes; the challenges, the wins, and all the messy bits in between. Continue Reading
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading